INTRODUCTION
The emergence of pathogenic bacterial resistance to available conventional antibiotics is a major threat in treatment of infectious diseases. [1] It is known that more than 70% of the clinical isolates of dental infection are resistant to existing antibiotics. [4] The resistance developed by bacteria is mainly due to alteration of target site, inactivation of drugs, or changes in the metabolic pathway. Peptides comprising about or less than 50 amino acids and possessing a net positive charge are grouped as AMPs. An overall positive charge in AMPs is due to Endodontic infections resulting in tooth decay are characterized by the presence of dental plaque and biofi lm comprising multiple species of microbes. [11] Several studies have shown that microorganisms which are involved in biofilm evades the host defence and also withstands the antimicrobial chemotherapy. [29] Hence, search for new agents which will eradicate those microbes becomes very essential. The current treatment of eradicating microbes in endodontic infection involves irrigating the root canal with powerful irrigants like chlorhexidine (CHX) and sodium hypochlorite (NaOCl). [10] These agents, owing to their chemical properties, can damage surrounding tissues over long residence in root canal. [26, 27] Several reports have shown that despite the use of such strong antiseptics, treatment failures occur. Furthermore, only 33% of teeth refi lled had showed endodontic success with a 24-77% of root canal treatment failure cases. Among several described reasons for the failure of conservative treatment models using the powerful irrigants includes their above said toxicity resulting in improper cleaning of root canal; anatomic complexity preventing irrigation of root canal in its entirety leaving resident bacteria in root canal for reinfection. [3] As Enterococcus faecalis, the predominant microbe in 4-40% of endodontic infections can also penetrate deep into the tubule, [20, 28] its complete removal from root canal is expected to provide good results in combating majority of root canal infection.
The main advantage of AMPs resides in the mechanism of their action, [5] which is different from that of conventional antibiotics currently used in endodontic treatment. [15] As AMPs demonstrate enhanced antimicrobial activity by disrupting bacterial membrane integrity along with attacking cytoplasmic targets, [13, 26] we hypothesized that AMPs could probably be a better agent in eradicating resident bacteria thereby preventing the possibility of re infection. Specifi cally with better tissue diffusion, we hypothesized that AMPs could kill E. faecalis at low μM concentration in a short period of time and also lack of microbial resistant mechanisms is an added advantage. [2, 23] In the present work, we synthesized eleven AMPs and screened them for activity against a panel of organisms such as E. faecalis, Staphylococcus aureus, Streptococcus spp., Candida albicans which are reported in endodontic infections. Results showed that VSL2 and VS2 possessed signifi cant activity against the microbe particularly E. faecalis. These peptides also proved to be biocompatible. The killing kinetics and the analysis of the mechanism of action of these chosen peptides against the target organism (E. faecalis) demonstrated signifi cant and fast effi cacy.
MATERIALS AND METHODS

Peptide synthesis
T h e p e p t i d e s w e r e s y n t h e s i z e d u s i n g standard Fmoc (9-fluorenylmethoxycarbonyl) c h e m i s t r y o n r i n k a m i d e M B H A (4-methylbenzhydrylamine hydrochloride salt) resin with DIPCDI (Diisopropylcarbodiimide) and HoBT (Hydroxybenzotriazole) as coupling agents. Fmoc group was removed by 20% piperidine in DMF (Dimethyl formamide). The coupling of amino acids and deprotection was monitored by Kaiser test. Once the coupling of amino acid was completed the amino termini of the peptide was acetylated using 20% acetic anhydride in dichloromethane (DCM); the resin was washed with DMF, methanol, DCM, and dried in a desiccator. Peptides were cleaved fi nally from the resin by stirring in a cleavage mixture containing 95% trifluoroacetic acid (TFA), 2.5% H 2 0 and 2.5% triisopropylsilane for 3h and TFA was evaporated, using high vacuum followed by precipitation of peptides by adding cold dry ether. Then the ether was fi ltered through a sinter funnel and the peptides were dissolved in 10% acetic acid and lyophilized. Same methodology was adopted to synthesize and characterize all the peptides. [18] Purifi cation and characterization of peptide Crude peptides were purified by reverse-phase high-performance liquid chromatography on a Deltapac C18 column (15-μm inside diameter [i.d.], 300 by 19 mm) using an acetonitrile-water linear gradient of 5-65% acetonitrile (0.1% TFA)-water (0.1% TFA) with a fl ow rate of 5 mL/min for 60 min, with detection at 214 and 280 nm. The purified peptides were reinjected into an analytical reversed-phase C18 column (Phenomenex; C18; 5-μm i.d; 250 by 4.6 mm) using an acetonitrile-water linear gradient of 5 to 65% acetonitrile (0.1% TFA)-water (0.1% TFA) at a fl ow rate of 1 mL/min over 60 min and were found to be 98% pure. Peptide mass was confi rmed by electro spray ionization mass spectrometry at International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Bacterial strains and growth
Microbial strains were obtained from clinical laboratory at Sri Ramachandra University. E. faecalis, S. aureus, Streptococcus spp., were maintained in brain heart infusion medium and C. albicans in sucrose dextrose medium at 37° under aerobic condition.
Agar diffusion test
The microbial suspension (E. faecalis, S. aureus, Streptococcus spp., and C. albicans) were swabbed on the agar plate and uniform wells were drilled on the agar plate to load the peptides of varying concentrations (10, 30, 50 , and 100 μM) and incubated at 37°C for 24 h to observe the zone of inhibition. Ampicillin served as positive control. Eleven peptides were screened to determine their antibacterial activity.
Morphological changes and biofilm assay by scanning electron microscopy E. faecalis was grown on Whatman No: 1 fi lter paper strips [31] and incubated overnight at 37°C. After incubation the stripes were treated with peptides at their MICs for 24 h and followed by immersion in neutralizing broth to stop the action of peptides. The strips were dried and coated with gold. The observations were made on supra 55, Carl Zeiss scanning electron microscope.
Quantitative assessment of bacterial viability in dentin by confocal laser scanning microscopy
The dentin block with a length of 4 mm was horizontally sectioned from each tooth at 1mm below the cementoenamel junction. The root canals inside the blocks were enlarged to a size of gates glidden drill #6. Each dentin blocks were fractured by making a thin groove in the middle of the specimen by using low speed hand piece with a small bur and then the specimens were fractured by a blade and hammer into semicylindrical halves. The processed dentin was infected with E. faecalis for 7 days. The contaminated specimens were washed with sterile water and were randomly divided into four groups: CHX, VSL2, VS2 and untreated. The specimens were disinfected with each drug at their MIC concentrations and incubated for 24 hours at 37°C. After the disinfection the dentin specimens were stained with fluorescein diacetate (FDA) which emits green fl uorescence in live cells and propidium iodide (PI) emits red fl uorescence in dead cells whose membranes are disrupted and binds to deoxyribonucleic acid (DNA). The uninfected specimens were stained under the same protocol and used as negative control. Fluorescence from the stained cells were viewed by using confocal laser scanning microscopy (CLSM) and by staining with FDA and PI the % of live and dead cells were computed. Post hoc multiple comparisons were used to compare the results at a signifi cance level of P > 0.05.
Quantifi cation of microbial load on ex vivo dentinal tubule model by real-time polymerase chain reaction Preparation of tooth samples
Freshly extracted central, tooth samples were collected (IEC approval No: IEC-NI/09/DEC/13/37) and immersed in 5.25% sodium hypochlorite to remove soft surface tissues and organic debris. The tooth samples were horizontally sectioned into coronal, middle, and apical sections using a carbide disc. [12] The root canal of each specimen was enlarged with a No: 10 round bur. The smear layer including organic and inorganic debris was removed by placing the samples in an ultrasonic bath containing 17% ethylenediaminetetraacetic acid, followed by rinsing with 5.25% NaOCl each for 5 min. The processed tooth samples were then sterilized by autoclaving at 121°C for 30 min.
Contamination of blocks
Sterilized tooth samples were immersed in E. faecalis suspension and incubated for 7 days at 37 o C. Samples which were not incubated with organisms served as negative control to confi rm the sterility of samples. Medium was changed every day. After incubation, the samples were gently washed with saline to remove the excess culture from the surface of the sample. Subsequently, 10 samples were used for each group and the inoculated samples were grouped as follows: After the incubation, the dentinal chips were harvested at 400 μm depth and the microbial load was quantifi ed using real-time (RT) polymerase chain reaction (PCR) from the chips.
Real-time PCR
DNA was isolated from the harvested dental chips by phenol chloroform isoamyl alcohol method. All the PCR reactions were done in 20 μl on detection system. Microbial load of E. faecalis present in dentinal tubule was determined using real time PCR (ABI 7900 HT). The assay is based on the detection of the 16s rRNA gene. Universal 16s rRNA primers were used for the amplifi cation. The forward primer (5' GATTAGATACCCTGGTAGTCC 3') reverse primer (5' CCCGGGAACGTATTCACCG 3') sequence were used for quantification of E. faecalis. The assay was performed by using SYBR green. [14] The following PCR conditions were adopted to amplify target: To amplify the product, 50°C for 2 min, 95°C for 10 min, 95°C for 15 s, and 60°C for 1 min for 35 cycles. The effi cacy of the compounds against E. faecalis was calculated based on the cycle threshold (CT) value. [30] Percentage of reduction = CT value of treated sample/ CT value of untreated Sample ×100
Platelet aggregation assay
Human blood sample from healthy volunteer was obtained in vacutainers containing the anticoagulant sodium citrate (IEC approval No: IEC-NI/09/ DEC /13/37). The citrated blood was centrifuged at 1000 rpm for 10 min and the supernatant was again centrifuged at 4000 rpm for 10 min to get platelet-rich plasma (PRP). 100 μL of PRP was treated with peptides (VSL2 and VS2) of varying concentrations (10, 50, and 100 μM). Collagen served as positive control. [16, 32] 
Statistical analysis
Comparison between treatments groups were conducted using the Kruskal-Wallis/analysis of variance analysis of variance on rank. Post hoc multiple comparison was done using Student-Newman-Keuls test. Comparison within each group was conducted by using Wilcoxon signed-rank test. Values of P > 0.05 were considered to be not signifi cant.
RESULTS
Zone inhibition assay carried out by agar diffusion test
Zone inhibition assay carried out on agar plates for 24 h showed that out of the 11 peptides screened [ Table 1 ], only two peptides, VSL2 and VS2, showed high activity against E. faecalis, S. aureus S. spp., and C. albicans, implicated in endodontic treatment failure shown in Figure 1 . The MIC for both the peptides was found to be 10 μM. The standard deviations of the zone size of both the peptides against various organisms are shown in Table 2 and the sequence of peptides in Table 3 .
Determination of the effect of peptides on microbe biofi lm formation and cell lysis as observed by electron microscopy Biofilm assay showed that treatment with the AMPS (VSL2 and VS2) lead to signifi cant reduction in microbial load as compared with the untreated control. SEM analysis showed that peptide treatment significantly decreased the degree of attachment of viable bacterial cells to matrix (Whatman paper) demonstrating their potency to inhibit biofilm formation. The morphological changes in the organisms are shown in Figure 2 and the reduction in biofi lm formation is shown in Figure 3 . Quantitative assessment of bacterial viability in dentin by CLSM The effi cacy of AMPS against E. faecalis penetrated into the dentinal tubules were assessed by CLSM [ Figure 4a ]. The results shows 58% dead cells in VSL2 treated tooth samples and 70% dead cells after VS2 treatment when compared with untreated samples which showed 6% of dead cells [ Figure 4b ]. The antibacterial effect of all the compounds was not statistically different from each other (P > 0.05).
Quantifi cation of microbial load on ex vivo dentinal tubule model by real-time PCR Antibacterial activity of VSL2 and VS2 tested against E. faecalis in dentinal tubule model by real-time PCR. The activity of peptides was comparable to vancomycin and the peptides high inhibitory activity at 400 μm after 24 h of treatment. VSL2 showed 97%, vancomycin and VS2 showed 98% reduction, and CHX showed 99% of reduction of E. faecalis after 24 h treatment.
Platelet aggregation assay
Platelet aggregation assay revealed that the AMPs did not cause aggregation of platelets even at 10 × MICs (100 μM) [ Figure 5 ] and hence they are biocompatible.
DICSUSSION
Endodontic treatment involves eradication of microbes invading the root canal and thereby teeth conservation. Use of high concentration irrigants and packaging of medicaments into the root canal are the two main modes of treatments of root canal infection. Irrigants usage is limited due to their toxicity profi le. Calcium hydroxide, the most widely used intracanal medicament, leads to incomplete eradication of the infecting microbes causing reinfection and tooth decay. Medicaments that are used commonly for root canal treatment also get distributed to the whole body from the root apex and hence may cause allergic reactions. Furthermore, few medicaments are potent carcinogens and hence use of such medicaments is prohibited in modern endodontic treatments. [25] Based on these observations from clinics, we tested our hypothesis that AMPs owing to their peptidic nature and hence biocompatibility could serve as useful intracanal medicament for eradication of microbes from infected root canal and hence (AMPs) could be one of the best possible alternatives. [17, 22] We showed that designed AMPs could serve as useful intracanal medicament and eradicate E. faecalis at 400 μm depth. Our initial screening study showed that out of 11 peptides tested, two demonstrated signifi cant activity against E. faecalis the most important pathogen involved in root canal infections. These peptides (VSL and VS2) showed activity against E. faecalis, S. aureus, and C. albicans but not against Streptococcus which was confi rmed thrice by repeating the experiments. Recent studies on vancomycin resistant Streptococcus have shown the presence of vanB gene in clinical isolates to be responsible; probably, these factors could be a reason for null activity of our peptides on Streptococcus. [33] Biofi lm is a structured consortium of bacteria embedded in a self-produced polymer matrix consisting of polysaccharide, protein and DNA [9] and this biofi lm reduction as determined by SEM showed that peptides prevented the aggregation of E. faecalis. This assay is signifi cant since formation of biofi lm, an important causative factor in dental infection was inhibited by the tested AMPs. The morphological changes documented by SEM analysis revealed that microbe death by cell membrane damage could probably be the major mechanism of action for the given antibacterial peptides. Similar observations were also reported earlier for other AMPs. [21, 24] The effi cacy of AMPS against the organisms invading the root canal was also proved by CLSM.
Ex vivo study on dentinal tubule model showed a drastic reduction in microbial load at different depths in root canal. Real-time PCR for 16s rRNA quantifi cation asserted the effi cacy of the AMPs as an intracanal medicament. We also observed that the AMPS needed to be in place for only 12 h, beyond which permanent dentures could be affi xed, showing high effi cacy and fast response of the medicament. Since our intention is to develop a safe intracanal medicament which can eradicate root canal pathogens, we also studied biocompatibility of the AMPs and these peptides did not cause platelet aggregation. 
